GKSL Quarterly Results, Profit & Loss, Balance Sheet (GKSL)

GKSL quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

Gujarat Kidney and Super Speciality Ltd (GKSL) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Gujarat Kidney and Super Speciality Ltd reported sales of ₹34.29 Cr, operating profit of ₹8.37 Cr (OPM 24.41%) and net profit of ₹5.32 Cr for the quarter ended Jun 2026. Figures in ₹ crore, consolidated where available.

GKSL quarterly results (₹ Cr)
MetricSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales9.4111.799.7815.2612.9323.2530.5834.29
YoY Sales growth----37.4197.2212.68124.71
Expenses4.557.197.176.647.8116.3524.2825.92
Operating Profit4.864.62.618.625.126.96.38.37
OPM51.65%39.02%26.69%56.49%39.6%29.68%20.6%24.41%
Other Income0.040.050.050.010.090.060.710.69
Interest0.160.170.160.180.280.60.820.66
Depreciation0.740.880.90.960.91.331.511.44
Profit before tax43.61.67.494.035.034.686.96
Tax26.25%29.72%16.88%27.77%28.54%26.44%-2.99%23.56%
Net Profit2.962.531.345.42.883.74.825.32
EPS in Rs0.530.440.230.850.470.370.640.66
GKSL profit & loss, annual (₹ Cr)
MetrictooltipsMar 2023Mar 2024Mar 2025Mar 2026TTM
Sales-054082101
Sales growth---744104119
Expenses-03245574
Operating Profit-02172727
OPM--41%41%33%26%
Other Income-01012
Interest-00122
Depreciation-00355
Profit before tax-02132121
Tax-0%25%26%21%-
Net Profit-02101717
EPS in Rs-00.491.661.972.14
Dividend Payout-0%0%0%0%-
GKSL balance sheet (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Sep 2025Mar 2026
Equity Capital0.20.21111.3716
Reserves0111522.13237
Borrowings06819.5329
Other Liabilities442122.6516
Total Liabilities4215575.68298
Fixed Assets0143129.43129
CWIP00000
Investments000012
Other Assets472446.25157
Total Assets4215575.68298
GKSL cash flows (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity0114-4
Cash from Investing Activity00-18-214
Cash from Financing Activity006228
Net Cash Flow01211
Free Cash Flow02-5-98
CFO/OP0%70%99%-14%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit0709921
GKSL ratios
MetricMar 2024Mar 2025Mar 2026
Debtor Days321138172
Inventory Days--82
Days Payable--339
Cash Conversion Cycle321138172
Working Capital Days100-2491
ROCE19%52%14%